"Low testosterone at first prostate-specific antigen failure and assess" by Andrew Renshaw

Menu

Skip to main content

All Publications

Andrew Renshaw, Miami Cardiac & Vascular InstituteFollow

Low testosterone at first prostate-specific antigen failure and assessment of risk of death in men with unfavorable-risk prostate cancer treated on prospective clinical trials

Publication Date

2018

Content Type

Article

PubMed ID:

Additional Authors:

Additional authors and institutional affiliations

Citation

Cancer (2018) 124(7):1383-1390

Restricted

Available to BHSF community via local IP address or BHSF login.

Find in your library

COinS